Lemonade (NYSE: LMND) officer sells 3,554 shares, still holds 70,771

Rhea-AI Filing Summary

Lemonade, Inc. reported an insider stock sale by its Chief Insurance Officer, John Peters. On 12/10/2025, he sold 3,554 shares of common stock at a price of $81 per share, in a transaction coded "S" for sale.

After this transaction, Peters beneficially owns 70,771 shares of Lemonade common stock, held directly. The filing is a routine Form 4 report of insider trading activity and does not describe any derivative securities transactions.

Insider Trade Summary

Net Seller: 3,554 shares ($287,874)

Net Sell 1 txn

Insider Peters John Sheldon

Role Chief Insurance Officer

Sold 3,554 shs ($288K)

Type	Security	Shares	Price	Value
Sale	COMMON STOCK	3,554	$81.00	$288K

Holdings After Transaction: COMMON STOCK — 70,771 shares (Direct)

Footnotes (1)

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Peters John Sheldon

(Last) (First) (Middle)

C/O LEMONADE, INC.

5 CROSBY STREET, 3RD FLOOR

(Street)

NEW YORK NY 10013

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Lemonade, Inc. [ LMND ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Insurance Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
COMMON STOCK	12/10/2025		S		3,554	D	$81	70,771	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Timothy Bixby, Attorney-in-Fact for John Peters	12/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Lemonade (LMND) report in this Form 4?

The filing reports that Chief Insurance Officer John Peters sold 3,554 shares of Lemonade, Inc. common stock on 12/10/2025.

At what price were the Lemonade (LMND) shares sold by the insider?

John Peters sold the 3,554 shares of Lemonade common stock at a price of $81 per share.

How many Lemonade (LMND) shares does the insider own after the sale?

Following the reported sale, John Peters beneficially owns 70,771 shares of Lemonade, Inc. common stock, held directly.

What is John Peters' role at Lemonade (LMND)?

John Peters is identified as an officer of Lemonade, Inc., serving as the company’s Chief Insurance Officer.

Does this Lemonade (LMND) Form 4 include any derivative securities activity?

The Table II section for derivative securities is present but contains no reported transactions, indicating no derivative activity in this filing.

Is the Lemonade (LMND) Form 4 filed for one or multiple reporting persons?

The document indicates that the Form is filed by one reporting person, relating to John Peters.